Technology evaluation for new business strategy
A biotech company was contemplating to change their scientific and business strategy. But they were unsure about the new direction and needed detailed information on scientific and commercial potential and possible problems.
FHR Consult performed an in-depth analysis of the envisioned scientific approach, the competitor landscape and also potential strategic partners. We summarized the results in a report, presented the key messages to the management and had several strategy discussions.
The Company decided to adopt a new and refined scientific and business strategy. They also entered early on into strategic collaborations to accelerate the implementation of the new strategy. In short time, the Company made good research progress and developed a new clinical pipeline. They were also successful in raising significant capital for the new strategy.
Learn more about our services for biotech, pharmaceutical and medtech companies and investors.